Man

Juan Carlos Casar Leturia

Profesor Asistente Adjunto

Escuela de Medicina, Pontificia Universidad Catolica de Chile

Santiago, Chile

Líneas de Investigación


Neuromuscular disorders; Myogenic progenitors/ cell-based therapy (Progenitores Musculares/Terapia Celular); Therapies for Muscular Dystrophy (Terapias para Distrofias Musculares); Palliative Care for ALS (Cuidados Paliativos en ELA)

Educación

  •  Licenciado en Medicina, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1995
  •  Doctorado en Ciencias Médicas, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2003
  •  Médico Cirujano, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1998
  •  Especialista en Neurología de adultos, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2007

Experiencia Académica

  •   Profesor Asistente Adjunto Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Santiago, Chile

    2007 - A la fecha

Experiencia Profesional

  •   Profesor asistente adjunto Full Time

    Depto. de Neurología, Escuela de Medicina, Pontificia Universidad Católica de Chile

    Santiago, Chile

    2007 - A la fecha

  •   Research Fellow Full Time

    Children's Hospital Boston/Harvard Medical School

    Boston, Estados Unidos

    2007 - 2011


 

Article (16)

Ganglionopatía Autonómica Autoinmune crónica. Una causa rara de disautonomia Chronic Autoimmune Autonomic Ganglionopathy. A rare case of dysautonomia
Non-dystrophic Myotonia Chilean Cohort With Predominance of the SCN4A Gly1306Glu Variant
Stem Cell Diferentiation and Therapeutic Use
Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis.
MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.
MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.
beta 4 Integrin Marks Interstitial Myogenic Progenitor Cells in Adult Murine Skeletal Muscle
Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells.
Regulation of DMD pathology by an ankyrin-encoded miRNA.
Inhibition of extracellular matrix assembly induces the expression of osteogenic markers in skeletal muscle cells by a BMP-2 independent mechanism.
Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation.
Structural and functional organization of synaptic acetylcholinesterase.
Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice.
Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation.
Reduced natriuresis after oral sodium load in cholestatic rats: role of compartment volumes and ANP.
Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle.

BookSection (2)

Capítulo 7. Semiología de las enfermedades de la motoneurona
Parte VIII. Neurología. Capítulos 37-47

Proyecto (4)

ROLE OF THE LPA/LPARs AXIS IN SKELETAL MUSCLE FIBROSIS
Participation of mesenchymal progenitors in the initiation of skeletal muscle fibrosis=> Effect of TGFβ/CTGF/PDGF and co-factors on fibroblasts’ ability to modulate myogenesis
MYOGENIC PRECURSOR TRANSPLANTATION AND DIRECT IN VIVO GENE TRANSFER TO MURINE SKELETAL MUSCLE
PARTICIPACION DE PROTEOGLICANES EN LA REGENERACION MUSCULAR ESQUELETICA EN EL RATON.
6
Juan Casar

Profesor Asistente Adjunto

Departamento de Neurología

Escuela de Medicina, Pontificia Universidad Catolica de Chile

Santiago, Chile